Abstract
Bioabsorbable stents offer an unproven but theoretically appealing means to address the deficiencies of current stent designs. Ideally, these stents would provide early postprocedural scaffolding support yet undergo a predictable process of reabsorption, thus removing the persistent stimulus for neointimal hyperplasia. Prototypes include polymeric formulations and magnesium-based absorbable metal stents. Current and future human trials will ascertain if bioabsorbable stents truly deliver a physiologic advantage in the treatment of peripheral occlusive disease.
Original language | English |
---|---|
Pages (from-to) | 295-298 |
Number of pages | 4 |
Journal | Perspectives in vascular surgery and endovascular therapy |
Volume | 18 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2006 |
Keywords
- absorbable implant
- hyperplasia
- lactic acid
- magnesium
- stent